IPO
Hancock Jaffe Laboratories, Inc.
We are a development stage medical device company developing biologic-based solutions that are designed to be life-enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease, or ESRD.
Symbol
HJLI
Price Range
$6.00 - $8.00
Anticipated Date
TBD
Underwriters
Network 1 Financial
To view the prospectus for Hancock Jaffe Laboratories, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277